Latest Breaking News On - Alta partners - Page 1 : comparemela.com

How Decent Health turned around its business

Decent has relaunched with a new approach to build level-funded health plans around direct primary care to serve small and medium-sized companies.

Progentos receives $65M to develop myelin regeneration therapies

Progentos Therapeutics Closes $65 Million Series A Financing to Advance Treatments for Multiple Sclerosis and Other Degenerative Diseases

Progentos Therapeutics, a biotech company addressing the critical unmet need to regenerate myelin and restore function for patients with Multiple Sclerosis (MS) and other demyelinating diseases, today announced its launch and the closing of a $65.

Progentos Therapeutics Closes $65M Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Forbion-backed biotech Progentos debuts with $65M for MS drug

BioPharma